Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,720 | 85 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $698.62 | 16 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $560.83 | 10 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $299.63 | 16 | $0 (2018) |
| Oyster Point Pharma, Inc. | $136.95 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $128.90 | 1 | $0 (2023) |
| Shire North American Group Inc | $124.25 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $114.02 | 6 | $0 (2022) |
| Harrow Eye, LLC | $106.52 | 1 | $0 (2024) |
| Avedro Inc. | $92.83 | 1 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $78.57 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.13 | 11 | Harrow Eye, LLC ($106.52) |
| 2023 | $620.31 | 14 | Sun Pharmaceutical Industries Inc. ($369.15) |
| 2022 | $413.59 | 14 | Sun Pharmaceutical Industries Inc. ($268.82) |
| 2021 | $103.32 | 6 | Novartis Pharmaceuticals Corporation ($66.64) |
| 2020 | $90.95 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($35.81) |
| 2019 | $492.82 | 9 | Bausch & Lomb, a division of Bausch Health US, LLC ($371.97) |
| 2018 | $419.60 | 9 | Johnson & Johnson Surgical Vision, Inc. ($135.05) |
| 2017 | $212.72 | 17 | Johnson & Johnson Surgical Vision, Inc. ($164.58) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $106.52 | General |
| Category: OPTOMETRY | ||||||
| 10/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Dry eyes | ||||||
| 10/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $38.90 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | CooperVision Inc. | Biofinity Contact Lens (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Devices | ||||||
| 08/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: EYE CARE | ||||||
| 07/09/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $37.95 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/24/2024 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Devices | ||||||
| 05/09/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Dry eyes | ||||||
| 04/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Ophthalmology | ||||||
| 02/09/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Dry eyes | ||||||
| 10/26/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $38.97 | General |
| Category: Ophthalmology | ||||||
| 10/19/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: TEPEZZA | ||||||
| 09/21/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: Ophthalmology | ||||||
| 08/11/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $38.43 | General |
| Category: Ophthalmology | ||||||
| 07/12/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $128.90 | General |
| 06/22/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Ophthalmology | ||||||
| 06/02/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $61.73 | General |
| Category: Ophthalmology | ||||||
| 05/15/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Ophthalmology | ||||||
| 04/11/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Ophthalmology | ||||||
| 04/04/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Ophthalmology | ||||||
| 04/03/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: DRY EYE | ||||||
| 01/27/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Ophthalmology | ||||||
| 01/19/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $119.85 | General |
| Category: Ophthalmology | ||||||
| 01/05/2023 | AbbVie Inc. | LUMIGAN (Drug), VUITY, ALPHAGAN P | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 435 | 463 | $114,880 | $29,681 |
| 2022 | 7 | 384 | 407 | $102,565 | $26,930 |
| 2021 | 8 | 455 | 485 | $124,480 | $34,543 |
| 2020 | 8 | 352 | 370 | $94,675 | $26,292 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 197 | 210 | $63,000 | $16,970 | 26.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 67 | 68 | $17,000 | $4,257 | 25.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 23 | 23 | $8,050 | $2,292 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 30 | $5,250 | $2,102 | 40.0% |
| 92134 | Imaging of retina | Office | 2023 | 55 | 62 | $9,610 | $1,792 | 18.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 38 | 38 | $5,890 | $875.96 | 14.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 20 | 20 | $3,500 | $771.88 | 22.1% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 12 | 12 | $2,580 | $620.64 | 24.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 175 | 184 | $55,200 | $14,930 | 27.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 38 | 38 | $13,300 | $3,984 | 30.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 43 | 46 | $11,500 | $2,950 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 31 | $5,425 | $1,844 | 34.0% |
| 92134 | Imaging of retina | Office | 2022 | 42 | 47 | $7,285 | $1,280 | 17.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 38 | 41 | $6,355 | $1,065 | 16.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 20 | 20 | $3,500 | $876.61 | 25.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 235 | 253 | $75,725 | $21,321 | 28.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 40 | 40 | $14,000 | $3,515 | 25.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 32 | 34 | $7,150 | $2,389 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 36 | $6,300 | $2,334 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 21 | $5,250 | $1,643 | 31.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 41 | 46 | $7,130 | $1,377 | 19.3% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 20 | 20 | $3,500 | $1,041 | 29.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 34 | 35 | $5,425 | $923.66 | 17.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 188 | 195 | $58,500 | $16,603 | 28.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 38 | 44 | $8,800 | $2,913 | 33.1% |
About Dr. Brandy Augustine, O.D
Dr. Brandy Augustine, O.D is a Optometrist healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457404170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandy Augustine, O.D has received a total of $2,720 in payments from pharmaceutical and medical device companies, with $367.13 received in 2024. These payments were reported across 85 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,720).
As a Medicare-enrolled provider, Augustine has provided services to 1,626 Medicare beneficiaries, totaling 1,725 services with total Medicare billing of $117,447. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Marietta, GA
- Active Since 01/18/2007
- Last Updated 12/06/2011
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1457404170
Products in Payments
- Cequa (Drug) $698.62
- ULTRA (Device) $359.61
- XIIDRA (Drug) $238.27
- BTOD (Device) $221.82
- Tecnis 1-piece IOL (Device) $186.45
- TYRVAYA (Drug) $136.95
- Tecnis iTec Preloaded Delivery System (Device) $113.18
- VEVYE (Drug) $106.52
- Photrexa (Drug) $92.83
- LUMIGAN (Drug) $77.22
- XDEMVY (Drug) $37.95
- RESTASIS MULTIDOSE (Drug) $33.28
- Rocklatan (Drug) $31.41
- TEPEZZA (Drug) $28.15
- Biofinity Contact Lens (Device) $24.83
- MIEBO (Drug) $23.10
- INFUSE (Device) $18.70
- MiSight Contact Lens (Device) $16.62
- VYZULTA (Drug) $16.17
- Clariti Contact Lens (Device) $15.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Marietta
Dr. Sander Dorfzaun, O.d, O.D
Optometrist — Payments: $10,549
Dr. Rakeshkumar Lakhani, O.d, O.D
Optometrist — Payments: $8,395
Dr. Kiran Bandali, O.d, O.D
Optometrist — Payments: $8,247
Gregg Russell, Od, OD
Optometrist — Payments: $7,465
Dr. Ivo Horak, O.d, O.D
Optometrist — Payments: $6,818
Jinen Shah, Od, OD
Optometrist — Payments: $6,736